CENTRAL ISLIP, N.Y.--(BUSINESS WIRE)--CVD Equipment Corporation (NASDAQ: CVV), a leading provider of chemical vapor deposition systems and materials announced today that it has completed the purchase of the Company’s planned additional facility, located at 555 North Research Place, Central Islip, NY. This new facility will be the primary manufacturing center for the Company’s wholly owned subsidiary, CVD Materials Corporation.
Leonard A. Rosenbaum, President and Chief Executive Officer stated, “With the completion of this purchase we now have the manufacturing space to accelerate our capabilities of providing materials, coatings, and surface treatments to meet our customers’ needs. We look forward to the expansion of our carbon composites and electronic material, Tantaline®, and newly acquired MesoScribe™, product lines. We also anticipate future growth, both organically and by possible future acquisitions. With the purchase behind us, we are now focusing on bringing the new facility on-line and for additional growth opportunities enabled by this additional 180,000 square foot facility.”
About CVD Equipment Corporation
CVD Equipment Corporation (NASDAQ: CVV) designs, develops, and manufactures a broad range of chemical vapor deposition, gas control, and other state-of-the-art equipment and process solutions used to develop and manufacture materials and coatings for research and industrial applications. This equipment is used by its customers to research, design, and manufacture these materials or coatings for aerospace engine components, medical implants, semiconductors, solar cells, smart glass, carbon nanotubes, nanowires, LEDs, MEMS, and other applications. Through its application laboratory, the Company provides process development support and process startup assistance with the focus on enabling tomorrow’s technologies™. Its wholly owned subsidiary CVD Materials Corporation provides advanced materials and metal surface treatments and coatings to serve demanding applications in the electronic, biomedical, petroleum, pharmaceutical, and many other industrial markets.